A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Pfizer
Novartis
Pfizer
Tango Therapeutics, Inc.
Amgen
Ikena Oncology
Aminex Therapeutics, Inc.
Actuate Therapeutics Inc.
Deciphera Pharmaceuticals, LLC
Five Prime Therapeutics, Inc.
Shenzhen BinDeBio Ltd.
BBB-Therapeutics B.V.
GE Healthcare
INSYS Therapeutics Inc
Thallion Pharmaceuticals